rs1509476
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002639.5(SERPINB5):c.567+2031G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.739 in 152,150 control chromosomes in the GnomAD database, including 41,986 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 41986 hom., cov: 32)
Consequence
SERPINB5
NM_002639.5 intron
NM_002639.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.557
Publications
2 publications found
Genes affected
SERPINB5 (HGNC:8949): (serpin family B member 5) Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of endopeptidase activity. Predicted to act upstream of or within several processes, including extracellular matrix organization; prostate gland morphogenesis; and regulation of epithelial cell proliferation. Located in cytoplasm. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.839 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SERPINB5 | ENST00000382771.9 | c.567+2031G>A | intron_variant | Intron 5 of 6 | 1 | NM_002639.5 | ENSP00000372221.4 | |||
| SERPINB5 | ENST00000464346.1 | n.249+2031G>A | intron_variant | Intron 2 of 3 | 3 | |||||
| SERPINB5 | ENST00000465652.5 | n.240+2031G>A | intron_variant | Intron 2 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.739 AC: 112409AN: 152032Hom.: 41943 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
112409
AN:
152032
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.739 AC: 112506AN: 152150Hom.: 41986 Cov.: 32 AF XY: 0.735 AC XY: 54655AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
112506
AN:
152150
Hom.:
Cov.:
32
AF XY:
AC XY:
54655
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
35128
AN:
41522
American (AMR)
AF:
AC:
10837
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
2367
AN:
3468
East Asian (EAS)
AF:
AC:
4033
AN:
5174
South Asian (SAS)
AF:
AC:
3343
AN:
4828
European-Finnish (FIN)
AF:
AC:
6930
AN:
10578
Middle Eastern (MID)
AF:
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47428
AN:
67974
Other (OTH)
AF:
AC:
1542
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1503
3006
4509
6012
7515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2592
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.